Back
Autolus Therapeutics Plc 10K Form
Sell
42
AUTL
Autolus Therapeutics Plc
Last Price:
$1.58
Seasonality Move:
0.92%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AUTL News And Ratings
See the #1 stock for the next 7 days that we like better than AUTL
AUTL Financial Statistics
Sales & Book Value
| Annual Sales: | $10.1M |
|---|---|
| Cash Flow: | $-79.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.75 |
| Price / Book: | 1.98 |
Profitability
| EPS (TTM): | -0.84410 |
|---|---|
| Net Income (TTM): | $-224.6M |
| Gross Margin: | $-9M |
| Return on Equity: | -59.51% |
| Return on Assets: | -30.04% |
Autolus Therapeutics Plc Earnings Forecast
Key Autolus Therapeutics Plc Financial Ratios
-
The Gross Profit Margin over the past 4 years for AUTL is -88.76%.
-
The Selling, General & Administrative Expenses for AUTL have been equal to 998.87% of Gross Profit Margin.
-
The Research & Development expenses have been 1,173.28% of Revenue.
-
The Net Earning history of AUTL is -2,180.45% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 6 years.
Autolus Therapeutics Plc Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AUTL |
| CUSIP: | 05280R |
| Website: | autolus.com |
Debt
| Debt-to-Equity Ratio: | 1.23 |
|---|---|
| Current Ratio: | 6.15 |
| Quick Ratio: | 4.83 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AUTL Technical Analysis vs Fundamental Analysis
Sell
42
Autolus Therapeutics Plc (AUTL)
is a Sell
Is Autolus Therapeutics Plc a Buy or a Sell?
-
Autolus Therapeutics Plc stock is rated a SellThe current Autolus Therapeutics Plc [AUTL] share price is $1.48. The Score for AUTL is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.